Why do the relative shares as calculated by the Arbuthnott Formula differ from the actual shares that NHS Boards receive of the final allocations?
This issue relates to the movement towards parity. SEHD decided to phase in the Arbuthnott Formula by way of ‘differential growth’ whereby all Boards would continue to enjoy real-terms growth in their allocations year-on-year, with those above parity (i.e. above their Arbuthnott target share) receiving less growth than those below parity until the new distribution was achieved. This is still ongoing.
Related Questions
- Why do the relative shares as calculated by the Arbuthnott Formula differ from the actual shares that NHS Boards receive of the final allocations?
- Why do the relative shares as calculated by the NRAC Formula differ from the actual shares that Boards receive of the final allocations?
- How is relative formula mass calculated?
